RADHAKISHAN PHARMACEUTICALS
TEMOSIDE TEMOZOLOMIDE CAPSULES

TEMOSIDE TEMOZOLOMIDE CAPSULES

TEMOSIDE TEMOZOLOMIDE CAPSULES Specification

  • Origin of Medicine
  • Pharmaceutical
  • Salt Composition
  • Temozolomide
  • Indication
  • Malignant Glioma, Glioblastoma Multiforme
  • Pacakaging (Quantity Per Box)
  • 5 or 20 capsules per box
  • Dosage Form
  • Solid
  • Drug Type
  • Allopathic
  • Ingredients
  • Temozolomide
  • Physical Form
  • Capsules
  • Function
  • Anticancer (alkylating agent)
  • Recommended For
  • Adults
  • Dosage
  • As prescribed by physician
  • Dosage Guidelines
  • Administer according to medical direction
  • Suitable For
  • Cancer treatment
  • Quantity
  • 5 or 20 Capsules per box
  • Storage Instructions
  • Store below 30C, protect from moisture
  • Route of Administration
  • Oral
  • Shelf Life
  • 24 months
  • Precautions
  • Monitor blood counts regularly; not for pregnant women
  • Registration
  • Approved under drug regulatory authority
  • Therapeutic Class
  • Cytotoxic Chemotherapy
  • Warning
  • Use only under medical supervision
  • Side Effects
  • Nausea, vomiting, fatigue, myelosuppression
  • Prescription Required
  • Yes
  • Strengths Available
  • 20 mg, 100 mg, 250 mg
  • Color of Capsule
  • White
 

TEMOSIDE TEMOZOLOMIDE CAPSULES Trade Information

  • Packaging Details
  • PACK OF 5 CAPSULES
 

About TEMOSIDE TEMOZOLOMIDE CAPSULES

Temoside Capsules

Specifications:

  • Product Name; Temoside
  • Content: Temozolomide
  • Form: Capsules
  • Strength: 20 Mg, 100 Mg, 250 Mg
  • Packing: Pack of 5 Capsules

Note :- Temoside is a prescription Drug and Should be Used under Proper Medical Guidance and Advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug................



Indications and Therapeutic Benefit

TEMOSIDE Capsules are specifically formulated for the treatment of malignant glioma and glioblastoma multiforme in adults. As an alkylating anticancer agent, temozolomide disrupts cancer cell replication, helping to slow tumor progression and improve clinical outcomes when prescribed as part of a comprehensive cancer therapy.


Administration and Dosage Guidelines

TEMOSIDE is administered orally, with dosage and duration determined by the treating physician based on individual patient needs and clinical protocols. The medicine should only be taken as directed, given its potent cytotoxic effects, and strict adherence to guidelines ensures efficacy and minimizes risk.


Safety, Precautions, and Monitoring

Due to possible side effects like nausea, vomiting, fatigue, and myelosuppression, regular monitoring of blood counts is essential during treatment. TEMOSIDE should be used under medical supervision, and it is contraindicated in pregnancy. Proper storage enhances shelf life and maintains drug purity.

FAQs of TEMOSIDE TEMOZOLOMIDE CAPSULES:


Q: How should TEMOSIDE Temozolomide Capsules be administered?

A: TEMOSIDE Capsules should be taken orally, as prescribed by your physician. The exact dosage and schedule will be tailored to your treatment plan, so its important to follow your healthcare providers instructions closely.

Q: What are the main uses and benefits of TEMOSIDE Capsules?

A: TEMOSIDE is primarily used for treating malignant glioma and glioblastoma multiforme in adults. The benefit of its active ingredient, temozolomide, lies in its ability to inhibit cancer cell growth, contributing to more effective cancer therapy.

Q: When should TEMOSIDE Capsules not be taken?

A: TEMOSIDE Capsules are contraindicated in pregnant women due to potential harm. Patients should also avoid taking this medication without medical supervision or if advised otherwise by their healthcare provider.

Q: Where should TEMOSIDE Capsules be stored for optimal shelf life?

A: Store TEMOSIDE Capsules below 30C and protect them from moisture. Keeping the capsules in their original packaging preserves their efficacy for up to 24 months.

Q: What precautions should be taken while using TEMOSIDE?

A: Regular blood count monitoring is essential, as TEMOSIDE can cause myelosuppression. Report any severe side effects like nausea or fatigue to your physician promptly, and always use the medication under strict medical supervision.

Q: What side effects can occur with TEMOSIDE Temozolomide Capsules?

A: Common side effects include nausea, vomiting, fatigue, and decreased blood cell counts (myelosuppression). Consult your doctor if symptoms worsen or persist, as additional management may be needed.

Q: Who is TEMOSIDE recommended for and what is its packaging?

A: TEMOSIDE is recommended for adults undergoing treatment for specific cancers, and is packaged in boxes containing either 5 or 20 capsules, based on the prescribed regimen.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Drugs & Medications Category

VELASOF SOFOSBUVIR AND VELPATSAVIR TABLETS

VELASOF SOFOSBUVIR AND VELPATSAVIR TABLETS

Pacakaging (Quantity Per Box) : 28 tablets

Recommended For : Chronic Hepatitis C Virus (HCV) infection

Quantity : 28 tablets per box

Indication : Treatment of chronic hepatitis C in adults

Drug Type : Other, Allopathic

Dosage Guidelines : Take one tablet orally once daily with or without food

RESOF L SOFOSBUVIR 400 MG AND LEDIPASVIR TABLETS

RESOF L SOFOSBUVIR 400 MG AND LEDIPASVIR TABLETS

Pacakaging (Quantity Per Box) : 1 bottle of 28 tablets

Recommended For : Chronic Hepatitis C infection

Quantity : 28 Tablets per bottle

Indication : Treatment of Hepatitis C Virus genotype 1 and 4

Drug Type : Other, Allopathic

Dosage Guidelines : Once daily

CYTOBLASTIN VINBLASTINE SULPHATE INJECTION

CYTOBLASTIN VINBLASTINE SULPHATE INJECTION

Pacakaging (Quantity Per Box) : 1 vial per box

Recommended For : Anticancer therapy, suitable for various types of cancers including Hodgkins disease, lymphomas, and testicular cancer.

Quantity : 10ml per vial

Indication : Treatment of Hodgkins disease, lymphosarcoma, choriocarcinoma, and testicular cancer

Drug Type : Medicine Raw Materials

Dosage Guidelines : As directed by a healthcare professional, dosage individualized based on patient condition

RESOF TOTAL SOFOSBUVIR AND VELPATASVIR TABLETS

RESOF TOTAL SOFOSBUVIR AND VELPATASVIR TABLETS

Pacakaging (Quantity Per Box) : 28 tablets

Recommended For : Chronic Hepatitis C infection

Quantity : 28 tablets per box

Indication : Treatment of chronic hepatitis C virus (HCV) infection

Drug Type : Other, Allopathic

Dosage Guidelines : Follow the dosage as directed by the healthcare professional



Back to top